Reset filter
Keywords
Orzecznictwo lekarskie ×
Mostra di più Keywords
Sommario
  1. 1. Test clinico
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
    1. 7.1. Anestesiologia
    1. 7.2. Dermatologia
    1. 7.3. orecchio naso gola
    1. 7.4. Geriatria
    1. 7.5. Ginecologia / Ostetricia
    1. 7.6. Medicina Interna
      1. Ematologia
      1. Malattie infettive
      1. Cardiologia / Angiologia
      1. pneumologia
      1. Gastroenterologia
      1. Nefrologia
      1. Endocrinologia / Malattie metaboliche
      1. Reumatologia
    1. 7.7. Neurologia
    1. 7.8. Oftalmologia
    1. 7.9. Cure palliative
    1. 7.10. Patologia / Forense
    1. 7.11. Pediatria
    1. 7.12. Psichiatria / Psicosomatica
    1. 7.13. Radiologia
    1. 7.14. Chirurgia
      1. Chirurgia generale / viscerale
      1. Neurochirurgia
      1. Chirurgia plastica
      1. Chirurgia toracica
      1. Trauma / Ortopedia
      1. Chirurgia vascolare
    1. 7.15. Urologia
    1. 7.16. Medicina odontoiatrica / OMS
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

3622 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Multiple Sclerosis NCT02485223

- 19/05/19 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02485223

Eligibility Dementia NCT00294307

- 01/03/17 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers; ODM derived from: https://clinicaltrials.gov/show/NCT00294307

Eligibility Multiple Sclerosis NCT02201108

- 16/05/19 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02201108

Eligibility Multiple Sclerosis NCT01079975

- 07/07/18 - 1 modulo, 2 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01079975

Eligibility Multiple Sclerosis NCT01592474

- 14/05/17 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of Brain Atrophy in CIS Patients on Avonex; ODM derived from: https://clinicaltrials.gov/show/NCT01592474

Eligibility Multiple Sclerosis NCT00321568

- 11/05/17 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Criteria, Exclusion Criteria
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00321568

Eligibility Multiple Sclerosis NCT00947232

- 06/07/18 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI; ODM derived from: https://clinicaltrials.gov/show/NCT00947232

Eligibility Multiple Sclerosis NCT02307877

- 17/05/19 - 1 modulo, 2 itemgroups, 12 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate; ODM derived from: https://clinicaltrials.gov/show/NCT02307877

Eligibility Multiple Sclerosis NCT00094068

- 27/10/16 - 1 modulo, 2 itemgroups, 34 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00094068

Eligibility Multiple Sclerosis NCT02200718

- 30/08/15 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of NeuroVax, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02200718 Principal Investigator: Dennis Bourdette, MD F.A.A.N.

Eligibility Post-stroke Depression NCT02472613

- 13/06/19 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Acupuncture for Ischemic Post-stroke Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02472613

Eligibility Multiple Sclerosis NCT02030197

- 17/01/19 - 1 modulo, 2 itemgroups, 10 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Impact of CRISP on Self-Efficacy, Loneliness, and Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02030197

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial